ArticleBreast cancer research and treatment2026

Metastatic phenotype and post-metastatic survival across HER2-0, HER2-low, and HER2-positive breast cancer.

Ali Sanjari Moghaddam et al.PubMed ↗Publisher ↗

No numbers read from the abstract.